文献速递精神分裂症与精神病性障碍儿童青少年精神

费城神经发育队列中精神病谱系症状的持续性:一项前瞻性两年随访研究

Persistence of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort: a prospective two-year follow-up.
PubMed 文献 · World Psychiatry · 2017-01-01

该研究基于费城神经发育队列的9498名8-21岁青少年初筛,选取有(249例)或无(254例)基线精神病谱系症状者,平均两年后随访。结果显示51.4%的青少年症状持续或加重,基线症状严重度高、整体功能低及既往精神科用药可预测症状持续。

要点

  • 约半数有基线精神病谱系症状的青少年在两年随访中症状持续或加重。
  • 基线症状严重度高、功能水平低和既往精神科用药是症状持续的预测因素。
  • 部分基线无症状但已有早期临床警告信号者随访中出现精神病谱系症状。

核心结论

  • 美国青少年中精神病谱系症状的病程多样,早期即可显现,支持将精神病风险视为动态发育过程进行探究。

研究设计与样本

  • 基于费城神经发育队列的9498名8-21岁青少年初筛,选取有(N=249)或无(N=254)基线精神病谱系症状者,平均两年后随访。
  • 随访采用前驱综合征结构化访谈(对初始筛查状态盲法)、分裂型人格问卷、其他临床测量、计算机化神经认知测试和神经影像。
  • 使用逻辑回归分析症状持续的临床和人口学预测因素。

主要发现

  • 在随访时,51.4%的青少年精神病谱系症状持续或加重。
  • 症状持续由基线亚临床精神病严重度更高、整体功能更低和既往精神科用药预测。
  • 基线有精神病谱系症状但随访无者,在基线和随访时症状水平和功能均较典型发育青少年更差。
  • 少数既往无明显症状但已有早期临床警告信号的青少年在随访中出现精神病谱系症状。

临床怎么用

  • 对具有基线精神病谱系症状、功能低下或既往精神科用药的青少年应加强监测,因其症状持续风险较高。
  • 临床应关注早期临床警告信号,即使当前无显著症状,也可能预示后续精神病谱系症状出现。

局限性

  • 样本基于初筛及既往神经影像参与情况选取,可能影响代表性。
  • 随访时间平均两年,不足以观察更长期病程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prospective evaluation of youths with early psychotic-like experiences can enrich our knowledge of clinical, biobehavioral and environmental risk and protective factors associated with the development of psychotic disorders. We aimed to investigate the predictors of persistence or worsening of psychosis spectrum features among US youth through the first large systematic study to evaluate subclinical symptoms in the community. Based on Time 1 screen of 9,498 youth (age 8-21) from the Philadelphia Neurodevelopmental Cohort, a subsample of participants was enrolled based on the presence (N=249) or absence (N=254) of baseline psychosis spectrum symptoms, prior participation in neuroimaging, and current neuroimaging eligibility. They were invited to participate in a Time 2 assessment two years on average following Time 1. Participants were administered the Structured Interview for Prodromal Syndromes, conducted blind to initial screen status, along with the Schizotypal Personality Questionnaire and other clinical measures, computerized neurocognitive testing, and neuroimaging. Clinical and demographic predictors of symptom persistence were examined using logistic regression. At Time 2, psychosis spectrum features persisted or worsened in 51.4% of youths. Symptom persistence was predicted by higher severity of subclinical psychosis, lower global functioning, and prior psychiatric medication at baseline. Youths classified as having psychosis spectrum symptoms at baseline but not at follow-up nonetheless exhibited comparatively higher symptom levels and lower functioning at both baseline and follow-up than typically developing youths. In addition, psychosis spectrum features emerged in a small number of young people who previously had not reported significant symptoms but who had exhibited early clinical warning signs. Together, our findings indicate that varying courses of psychosis spectrum symptoms are evident early in US youth, supporting the importance of investigating psychosis risk as a dynamic developmental process. Neurocognition, brain structure and function, and genomics may be integrated with clinical data to provide early indices of symptom persistence and worsening in youths at risk for psychosis.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Calkins ME, Moore TM, Satterthwaite TD, et al. Persistence of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort: a prospective two-year follow-up. World Psychiatry. 2017. PMID: 28127907. doi:10.1002/wps.20386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。